Good Korean Consulting Group

Counseling room

TitleCanada Approves World's First mRNA Flu Vaccine — For Ages 50 and Older2026-11-10 13:42
Category Health/Beauty
Name Level 10

Health Canada has approved the world's first mRNA-based seasonal flu vaccine and a combined flu and COVID-19 vaccine. This was announced by Moderna on November 6, and the two approved vaccines are the flu vaccine mFLUSIVA and the combined flu and COVID-19 vaccine mCOFLU.

  • Target: Both vaccines have been approved for adults aged 50 and older.
  • World's first: Canada is the first country in the world to approve both vaccines. mFLUSIVA was approved by the U.S. FDA in August 2026, and the combination vaccine was approved by the European Union in April 2026.
  • Clinical trial results: In a Phase 3 clinical trial involving approximately 40,800 adults aged 50 and older across 11 countries, mFLUSIVA was reported to have a relative efficacy 26.6% higher than existing standard-dose flu vaccines (study results to be published in the New England Journal of Medicine in May 2026).
  • Don't wait for this winter's vaccination: It appears that the newly approved vaccine will be difficult to supply in large quantities for the upcoming 2026-27 respiratory disease season. Health authorities and experts advise that it is best to get the existing flu vaccine currently available at pharmacies and clinics this year.
  • Supply timing: Moderna stated that it will work with Canadian health authorities and vaccination partners to move forward with future supply plans, but a confirmed pharmacy supply timing has not yet been announced.

Source: Pharmaceutical Technology
https://www.pharmaceutical-tech.com/pressreleases/health-canada-authorizes-modernas-mrna-influenza

Comment

(Enter the auto register prevention code)